T. Rowe Price led with nine products registered, while Credicorp Capital, Eastspring, Invesco, Silver Lake and Veritas Capital completed the list. each with one product approved.
CCR Monthly Approval Report – April 2022
BlackRock and Lazard led, both with three mutual funds approved in the month, while Jupiter, UBS and State Street with one product each completed the list.
CCR Monthly Approval Report – March 2022
Nordea lead with four equity funds approved, followed by Bci, Candriam, JSS, Schroders, Vontobel and Arcano with one product each.
CCR Monthly Approval Report – February 2022
A total of 15 products were added in the month from four different asset managers: iShares, Allianz, M&G and Vanguard.
CCR Monthly Approval Report – January 2022
Moneda, AlpInvest Partners, Astorg Partners , HarbourVest Partners and HG CP were the managers registering products in January 2022.
CCR Monthly Approval Report – December 2021
Vanguard led the list of registered investment products in the month with two ETFs, followed by Man GLG with one mutual fund and Cheyne Capital with one alternative product approved.
CCR Monthly Approval Report – November 2021
Pictet, Fidelity, Robeco, Neuberger Berman, Francisco Partners, StepStone Group and NREP AB were the fund sponsors gaining approval for new products.
CCR Monthly Approval Report – October 2021
A total of 21 products were added in the month from 10 different asset managers: Schroder, Invesco, JP Morgan, Moneda, BNP Paribas, Goldman Sachs, Janus Henderson, UBAM, Vanguard and KKR.
CCR Monthly Approval Report – September 2021
Baillie Gifford, Candriam, Echiquier, JP Morgan (ETF), New Capital and TDR were the fund sponsors gaining approval for new products in September.
CCR Monthly Approval Report – August 2021
A total of seven products were added in the month from eight different asset managers: Allianz, Amundi, BNP Paribas, Golden Tree, Hines, Nomura, and PineBridge.